{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:43:24Z","timestamp":1790142204136,"version":"4.0.1"},"reference-count":85,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fundam Clin Pharmacol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1111\/fcp.12256","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T07:44:46Z","timestamp":1480059886000},"page":"136-146","source":"Crossref","is-referenced-by-count":46,"title":["Purinergic receptors: new targets for the treatment of gout and fibrosis"],"prefix":"10.1111","volume":"31","author":[{"given":"Thomas","family":"Gicquel","sequence":"first","affiliation":[{"name":"Laboratoire de toxicologie biologique et m\u00e9dico-l\u00e9gale; CHU Rennes; F-35033 Rennes France"},{"name":"UMR991 INSERM; Facult\u00e9 de Pharmacie; Universit\u00e9 Rennes 1; F-35043 Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Le Dar\u00e9","sequence":"additional","affiliation":[{"name":"UMR991 INSERM; Facult\u00e9 de Pharmacie; Universit\u00e9 Rennes 1; F-35043 Rennes France"},{"name":"CHU Rennes, P\u00f4le Pharmacie; F-35033 Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Boichot","sequence":"additional","affiliation":[{"name":"UMR991 INSERM; Facult\u00e9 de Pharmacie; Universit\u00e9 Rennes 1; F-35043 Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lagente","sequence":"additional","affiliation":[{"name":"UMR991 INSERM; Facult\u00e9 de Pharmacie; Universit\u00e9 Rennes 1; F-35043 Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"key":"10.1111\/fcp.12256-BIB0001|fcp12256-cit-0001","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2174\/0929867322666141210155311","article-title":"P2X receptors and inflammation","volume":"22","author":"Di Virgilio","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1111\/fcp.12256-BIB0002|fcp12256-cit-0002","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1164\/rccm.201003-0359OC","article-title":"Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis","volume":"182","author":"Riteau","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1111\/fcp.12256-BIB0003|fcp12256-cit-0003","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cellimm.2012.05.005","article-title":"The His155Tyr (489C>T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cell","volume":"276","author":"Portales-Cervantes","year":"2012","journal-title":"Cell. Immunol."},{"key":"10.1111\/fcp.12256-BIB0004|fcp12256-cit-0004","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.semarthrit.2013.04.007","article-title":"P2X7R: a potential key regulator of acute gouty arthritis","volume":"43","author":"Tao","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1111\/fcp.12256-BIB0005|fcp12256-cit-0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nm1617","article-title":"Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells","volume":"13","author":"Idzko","year":"2007","journal-title":"Nat. Med."},{"key":"10.1111\/fcp.12256-BIB0006|fcp12256-cit-0006","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/jid.2011.344","article-title":"Purinergic signaling in healthy and diseased skin","volume":"132","author":"Burnstock","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1111\/fcp.12256-BIB0007|fcp12256-cit-0007","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0707266","article-title":"Novel P2X7 receptor antagonists ease the pain","volume":"151","author":"King","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1111\/fcp.12256-BIB0008|fcp12256-cit-0008","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1046\/j.1471-4159.2000.0751600.x","article-title":"Unique functional properties of a sensory neuronal P2X ATP-gated channel from zebrafish","volume":"75","author":"Bou\u00e9-Grabot","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1111\/fcp.12256-BIB0009|fcp12256-cit-0009","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"10.1111\/fcp.12256-BIB0010|fcp12256-cit-0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1189\/jlb.0802418","article-title":"Alerting and tuning the immune response by extracellular nucleotides","volume":"73","author":"Sala","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1111\/fcp.12256-BIB0011|fcp12256-cit-0011","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharmthera.2005.04.013","article-title":"Adenosine 5\u2032-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation","volume":"112","author":"Bours","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1111\/fcp.12256-BIB0012|fcp12256-cit-0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fphys.2014.00096","article-title":"Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases","volume":"5","author":"Velasquez","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1111\/fcp.12256-BIB0013|fcp12256-cit-0013","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.physiol.70.113006.100630","article-title":"Signaling at purinergic P2X receptors","volume":"71","author":"Surprenant","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1111\/fcp.12256-BIB0014|fcp12256-cit-0014","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(24)01373-5","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1111\/fcp.12256-BIB0015|fcp12256-cit-0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2938","article-title":"Immune cell regulation by autocrine purinergic signalling","volume":"11","author":"Junger","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1111\/fcp.12256-BIB0016|fcp12256-cit-0016","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.coph.2009.02.004","article-title":"Purinergic receptors in airway epithelia","volume":"9","author":"Lazarowski","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1111\/fcp.12256-BIB0017|fcp12256-cit-0017","doi-asserted-by":"crossref","first-page":"e1629","DOI":"10.1038\/cddis.2014.576","article-title":"The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine","volume":"6","author":"Baron","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1111\/fcp.12256-BIB0018|fcp12256-cit-0018","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1111\/fcp.12256-BIB0019|fcp12256-cit-0019","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0163-7258(94)00048-4","article-title":"Purinoceptors: are there families of P2X and P2Y purinoceptors ?","volume":"64","author":"Abbracchio","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"10.1111\/fcp.12256-BIB0020|fcp12256-cit-0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2005-869519","article-title":"Overview of the P2 receptors","volume":"31","author":"Boeynaems","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1111\/fcp.12256-BIB0021|fcp12256-cit-0021","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"10.1111\/fcp.12256-BIB0022|fcp12256-cit-0022","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.juro.2012.07.095","article-title":"Adenosine triphosphate induced P2Y2 receptor activation induces proinflammatory cytokine release in uroepithelial cells","volume":"188","author":"Kruse","year":"2012","journal-title":"J. Urol."},{"key":"10.1111\/fcp.12256-BIB0023|fcp12256-cit-0023","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuropharm.2008.06.067","article-title":"ATP-gated P2X cation-channels","volume":"56","author":"Jarvis","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1111\/fcp.12256-BIB0024|fcp12256-cit-0024","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00018-007-6497-0","article-title":"Purine and pyrimidine receptors","volume":"64","author":"Burnstock","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1111\/fcp.12256-BIB0025|fcp12256-cit-0025","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/emboj\/17.11.3016","article-title":"P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels","volume":"17","author":"Nicke","year":"1998","journal-title":"EMBO J."},{"key":"10.1111\/fcp.12256-BIB0026|fcp12256-cit-0026","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1124\/mol.107.035980","article-title":"Evidence for functional P2X4\/P2X7 heteromeric receptors","volume":"72","author":"Guo","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1111\/fcp.12256-BIB0027|fcp12256-cit-0027","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/7233","article-title":"Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds","volume":"2","author":"Khakh","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1111\/fcp.12256-BIB0028|fcp12256-cit-0028","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature04886","article-title":"P2X receptors as cell-surface ATP sensors in health and disease","volume":"442","author":"Khakh","year":"2006","journal-title":"Nature"},{"key":"10.1111\/fcp.12256-BIB0029|fcp12256-cit-0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fncel.2013.00250","article-title":"Heteromeric assembly of P2X subunits","volume":"7","author":"Saul","year":"2013","journal-title":"Front Cell Neurosci."},{"key":"10.1111\/fcp.12256-BIB0030|fcp12256-cit-0030","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J. Immunol."},{"key":"10.1111\/fcp.12256-BIB0031|fcp12256-cit-0031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","article-title":"P2X ion channel receptors and inflammation","volume":"12","author":"Burnstock","year":"2016","journal-title":"Purinergic Signal"},{"key":"10.1111\/fcp.12256-BIB0032|fcp12256-cit-0032","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","article-title":"Cellular distribution and functions of P2 receptor subtypes in different systems","volume":"240","author":"Burnstock","year":"2004","journal-title":"Int. Rev. Cytol."},{"key":"10.1111\/fcp.12256-BIB0033|fcp12256-cit-0033","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00424-006-0070-9","article-title":"Pharmacology of P2X channels","volume":"452","author":"Gever","year":"2006","journal-title":"Eur. J. Physiol."},{"key":"10.1111\/fcp.12256-BIB0034|fcp12256-cit-0034","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1074\/jbc.272.9.5482","article-title":"The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA","volume":"272","author":"Rassendren","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1111\/fcp.12256-BIB0035|fcp12256-cit-0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science"},{"key":"10.1111\/fcp.12256-BIB0036|fcp12256-cit-0036","doi-asserted-by":"crossref","first-page":"25813","DOI":"10.1074\/jbc.M109.033134","article-title":"A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice","volume":"284","author":"Nicke","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1111\/fcp.12256-BIB0037|fcp12256-cit-0037","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1093\/emboj\/20.22.6347","article-title":"Proteomic and functional evidence for a P2X7 receptor signalling complex","volume":"20","author":"Kim","year":"2001","journal-title":"EMBO J."},{"key":"10.1111\/fcp.12256-BIB0038|fcp12256-cit-0038","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/S0021-9258(18)61477-2","article-title":"Extracellular ATP4\u2212 promotes cation fluxes in the J774 mouse macrophage cell line","volume":"262","author":"Steinberg","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1111\/fcp.12256-BIB0039|fcp12256-cit-0039","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.febslet.2006.12.056","article-title":"Pannexin 1 is part of the pore forming unit of the P2X7 receptor death complex","volume":"581","author":"Locovei","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1111\/fcp.12256-BIB0040|fcp12256-cit-0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1440-1681.12214","article-title":"Involvement of purinergic receptors and NLRP3-inflammasome pathway in the ATP-induced cytokine release from macrophages","volume":"41","author":"Gicquel","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1111\/fcp.12256-BIB0041|fcp12256-cit-0041","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.lpm.2016.01.006","article-title":"The NLRP3 inflammasome: physiopathology and therapeutic application","volume":"45","author":"Gicquel","year":"2016","journal-title":"Presse Med."},{"key":"10.1111\/fcp.12256-BIB0042|fcp12256-cit-0042","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1111\/fcp.12256-BIB0043|fcp12256-cit-0043","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00018-010-0567-4","article-title":"Inflammasomes: current understanding and open questions","volume":"68","author":"Bauernfeind","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1111\/fcp.12256-BIB0044|fcp12256-cit-0044","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1100613","article-title":"Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome","volume":"187","author":"Bauernfeind","year":"2011","journal-title":"J. Immunol."},{"key":"10.1111\/fcp.12256-BIB0045|fcp12256-cit-0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger?","volume":"327","author":"Schroder","year":"2010","journal-title":"Science"},{"key":"10.1111\/fcp.12256-BIB0046|fcp12256-cit-0046","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.200808-1274OC","article-title":"Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis","volume":"179","author":"Gasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1111\/fcp.12256-BIB0047|fcp12256-cit-0047","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11302-010-9205-8","article-title":"Ivermectin-dependent release of IL-1beta in response to ATP by peritoneal macrophages from P2X(7)-KO mice","volume":"4","author":"Seil","year":"2010","journal-title":"Purinergic Signal"},{"key":"10.1111\/fcp.12256-BIB0048|fcp12256-cit-0048","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4049\/jimmunol.1003746","article-title":"P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals","volume":"188","author":"Uratsuji","year":"2012","journal-title":"J. Immunol."},{"key":"10.1111\/fcp.12256-BIB0049|fcp12256-cit-0049","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2337\/db12-0242","article-title":"Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection","volume":"62","author":"Vergani","year":"2013","journal-title":"Diabetes"},{"key":"10.1111\/fcp.12256-BIB0050|fcp12256-cit-0050","first-page":"1183","article-title":"Advance in the research on P2X7 and inflammatory respiratory diseases","volume":"48","author":"Cao","year":"2013","journal-title":"Yao Xue Xue Bao"},{"key":"10.1111\/fcp.12256-BIB0051|fcp12256-cit-0051","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2174\/0929867322666141212120926","article-title":"Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential","volume":"22","author":"Baudelet","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1111\/fcp.12256-BIB0052|fcp12256-cit-0052","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/acsmedchemlett.6b00083","article-title":"Promising therapeutic potential of P2X7 modulators","volume":"7","author":"Abdel-Magid","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1111\/fcp.12256-BIB0053|fcp12256-cit-0053","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1096\/fj.14-267393","article-title":"IL-1\u03b2 production is dependent of the activation of purinergic receptors and NLRP3 pathway in human macrophages","volume":"29","author":"Gicquel","year":"2015","journal-title":"FASEB J."},{"key":"10.1111\/fcp.12256-BIB0054|fcp12256-cit-0054","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12026-011-8203-4","article-title":"Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions","volume":"50","author":"Lenertz","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1111\/fcp.12256-BIB0055|fcp12256-cit-0055","doi-asserted-by":"crossref","first-page":"e00360","DOI":"10.1042\/BSR20160107","article-title":"Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis","volume":"36","author":"Robert","year":"2016","journal-title":"Biosci. Rep."},{"key":"10.1111\/fcp.12256-BIB0056|fcp12256-cit-0056","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann. Int. Med."},{"key":"10.1111\/fcp.12256-BIB0057|fcp12256-cit-0057","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1164\/ajrccm.157.4.9707039","article-title":"Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification","volume":"157","author":"Katzenstein","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1111\/fcp.12256-BIB0058|fcp12256-cit-0058","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1164\/ajrccm.157.4.nhlbi-10","article-title":"Lung inflammation and fibrosis","volume":"157","author":"Ward","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1111\/fcp.12256-BIB0059|fcp12256-cit-0059","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12931-016-0328-5","article-title":"Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis","volume":"17","author":"Lehtonen","year":"2016","journal-title":"Respir. Res."},{"key":"10.1111\/fcp.12256-BIB0060|fcp12256-cit-0060","doi-asserted-by":"crossref","first-page":"26385","DOI":"10.3402\/ecrj.v2.26385","article-title":"Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine","volume":"2","author":"Myll\u00e4rniemi","year":"2015","journal-title":"Eur. Clin. Respir. J."},{"key":"10.1111\/fcp.12256-BIB0061|fcp12256-cit-0061","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/jcm5090078","article-title":"Real world experiences: pirfenidone and nintedanib are effective and well tolerated treatments for idiopathic pulmonary fibrosis","volume":"5","author":"Hughes","year":"2016","journal-title":"J Clin Med."},{"key":"10.1111\/fcp.12256-BIB0062|fcp12256-cit-0062","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12931-014-0157-3","article-title":"Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis","volume":"15","author":"Hostettler","year":"2014","journal-title":"Respir. Res."},{"key":"10.1111\/fcp.12256-BIB0063|fcp12256-cit-0063","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pupt.2016.07.009","article-title":"Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"40","author":"Rogliani","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1111\/fcp.12256-BIB0064|fcp12256-cit-0064","doi-asserted-by":"crossref","first-page":"C779","DOI":"10.1152\/ajpcell.00381.2013","article-title":"Cellular mechanisms of tissue fibrosis. Purinergic signaling and response in fibroblasts and tissue fibrosis","volume":"306","author":"Lu","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1111\/fcp.12256-BIB0065|fcp12256-cit-0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis - from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1111\/fcp.12256-BIB0066|fcp12256-cit-0066","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1111\/fcp.12256-BIB0067|fcp12256-cit-0067","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.freeradbiomed.2012.02.010","article-title":"P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice","volume":"52","author":"Chatterjee","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1111\/fcp.12256-BIB0068|fcp12256-cit-0068","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/mmr.2013.1807","article-title":"P2X7 blockade attenuates mouse liver fibrosis","volume":"9","author":"Huang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1111\/fcp.12256-BIB0069|fcp12256-cit-0069","doi-asserted-by":"crossref","first-page":"172493","DOI":"10.1155\/2015\/172493","article-title":"P2X7 Receptor as a key player in oxidative stress-driven cell fate in nonalcoholic steatohepatitis","volume":"2015","author":"Chatterjee","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1111\/fcp.12256-BIB0070|fcp12256-cit-0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1165\/ajrcmb.27.2.4674","article-title":"Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of \u201cfibrosis-prone\u201d and \u201cfibrosis-resistant\u201d mouse strains","volume":"27","author":"Kolb","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1111\/fcp.12256-BIB0071|fcp12256-cit-0071","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.2174\/1381612822666160608114424","article-title":"P2Y12 receptor antagonists: which one to choose? A systematic review and meta-analysis","volume":"22","author":"Briasoulis","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1111\/fcp.12256-BIB0072|fcp12256-cit-0072","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1084\/jem.20092489","article-title":"Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity","volume":"207","author":"Weber","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1111\/fcp.12256-BIB0073|fcp12256-cit-0073","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2009.05.018","article-title":"The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice","volume":"204","author":"Honore","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1111\/fcp.12256-BIB0074|fcp12256-cit-0074","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1358\/dnp.2008.21.8.1265800","article-title":"Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1","volume":"21","author":"Pelegrin","year":"2008","journal-title":"Drug News Perspect."},{"key":"10.1111\/fcp.12256-BIB0075|fcp12256-cit-0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/13543784.2011.578068","article-title":"A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases","volume":"20","author":"Arulkumaran","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1111\/fcp.12256-BIB0076|fcp12256-cit-0076","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bmc.2013.10.054","article-title":"Purinergic receptor P2X\u2087: a novel target for anti-inflammatory therapy","volume":"22","author":"Mehta","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1111\/fcp.12256-BIB0077|fcp12256-cit-0077","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1111\/fcp.12256-BIB0078|fcp12256-cit-0078","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1111\/fcp.12256-BIB0079|fcp12256-cit-0079","doi-asserted-by":"crossref","first-page":"G32","DOI":"10.1152\/ajpgi.00282.2009","article-title":"Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration","volume":"299","author":"Cesaro","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1111\/fcp.12256-BIB0080|fcp12256-cit-0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/0008-5472.CAN-14-1778","article-title":"Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer","volume":"75","author":"Hofman","year":"2015","journal-title":"Cancer Res."},{"key":"10.1111\/fcp.12256-BIB0081|fcp12256-cit-0081","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"key":"10.1111\/fcp.12256-BIB0082|fcp12256-cit-0082","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/WNR.0b013e3283179333","article-title":"Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease","volume":"19","author":"Ryu","year":"2008","journal-title":"NeuroReport"},{"key":"10.1111\/fcp.12256-BIB0083|fcp12256-cit-0083","doi-asserted-by":"crossref","first-page":"e1001888","DOI":"10.1371\/journal.pmed.1001888","article-title":"P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy","volume":"12","author":"Sinadinos","year":"2015","journal-title":"PLoS Med."},{"key":"10.1111\/fcp.12256-BIB0084|fcp12256-cit-0084","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuropharm.2015.05.005","article-title":"Purinergic signaling in retinal degeneration and regeneration","volume":"104","author":"Reichenbach","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1111\/fcp.12256-BIB0085|fcp12256-cit-0085","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.bbamem.2014.10.029","article-title":"Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives","volume":"1848","author":"Roger","year":"2015","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Fundamental & Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ffcp.12256","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/fcp.12256\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T21:28:41Z","timestamp":1749763721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.12256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,30]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1111\/fcp.12256","archive":["Portico"],"relation":{},"ISSN":["0767-3981"],"issn-type":[{"value":"0767-3981","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12,30]]}}}